Download Sunnybrook Health Sciences Centre Odette

 Sunnybrook Health Sciences Centre
Odette Cancer Centre, Room T2
2075 Bayview Ave., Toronto ON
Canada M4N 3M5
Tel: 1-416-480-5248
Fax: 1-416-480-6002
E-mail: [email protected]
July 2, 2015
Martin R. Chasen, MD
Managing Editor, Current Oncology
Department of Oncology, Division of Palliative Care
Elisabeth Bruyere Hospital
Ottawa, ON
K1N 5C8
Tel: 1-613-562-6262 ext. 1265
Email: [email protected]
Dear Dr. Chasen,
RE: Manuscript entitled “Cross-comparison of cancer drug approvals among
international regulatory bodies”
We are submitting an article to Current Oncology that answers several important
questions about the current state of cancer drug approval processes across the major
international regulatory agencies. Our manuscript details the first systematic analysis of
cancer drug approvals and underscores the marked differences in cancer drug approval
processes between regulatory agencies worldwide, including FDA, European authorities
and Health Canada. The results from the study were selected for oral presentation at the
Public Health and Economics Session at the 2014 ESMO Congress in Madrid and were
among the results shared in the opening press conference for the congress.
We anticipate that readers of Current Oncology would benefit from this work and will
help the reader better understand the framework of cancer drug approvals and this will
also help to create a dialogue amongst clinicians and government agencies to address
these findings.
We hope that you will find our analysis suitable for Current Oncology and we look
forward to hearing back from you.
Sincerely,
Sunil Verma, MD, FRCSC
Medical Oncologist
Sunnybrook Odette Cancer Centre, Toronto ON
Assistant Professor, University of Toronto